Clinical Trials Browser

OTHER_GOV × Breast Neoplasms × Goserelin × Clear all

NCT03423199 2024-03-22

PATHWAY

Phase 3 Unknown

Breast Neoplasms, Neoplasm Metastasis

NCT00532272 2011-06-27

Goserelin/Letrozole in Premenopausal Patients vs Letrozole Alone in Postmenopausal Patients With MBC

Phase 2 Completed

Breast Neoplasms